Sign in Sign up for free

Last updated: 23 July 2019 at 12:04am EST

Arthur Md Kornberg Net Worth




The estimated Net Worth of Arthur Md Kornberg is at least $298 Thousand dollars as of 11 May 2004. Arthur Kornberg owns over 1,000 units of XOMA Royalty stock worth over $298,320 and over the last 22 years Arthur sold XOMA stock worth over $0.

Arthur Kornberg XOMA stock SEC Form 4 insiders trading

Arthur has made over 1 trades of the XOMA Royalty stock since 2004, according to the Form 4 filled with the SEC. Most recently Arthur exercised 1,000 units of XOMA stock worth $3,380 on 11 May 2004.

The largest trade Arthur's ever made was exercising 1,000 units of XOMA Royalty stock on 11 May 2004 worth over $3,380. On average, Arthur trades about 167 units every 0 days since 2003. As of 11 May 2004 Arthur still owns at least 11,000 units of XOMA Royalty stock.

You can see the complete history of Arthur Kornberg stock trades at the bottom of the page.



What's Arthur Kornberg's mailing address?

Arthur's mailing address filed with the SEC is , , , , .

Insiders trading at XOMA Royalty

Over the last 22 years, insiders at XOMA Royalty have traded over $74,428,857 worth of XOMA Royalty stock and bought 6,217,869 units worth $44,091,555 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Partners L P/Ilbiotechnolog..., and Bros. Advisors Lp667, L.P.B.... On average, XOMA Royalty executives and independent directors trade stock every 31 days with the average trade being worth of $3,397,377. The most recent stock trade was executed by Owen Hughes on 2 October 2023, trading 1,000 units of XOMA stock currently worth $13,830.



What does XOMA Royalty do?

xoma has an extensive portfolio of products, programs, and technologies that are the subject of licenses the company has in place with other biotech and pharmaceutical companies. many of these licenses are the result of the company's pioneering efforts in the discovery and development of antibody therapeutics. there are more than 20 such programs that are fully funded by partners and could produce milestone payments and royalty payments in the future. in order to maximize its value in a licensing transaction, xoma continues to invest in x358, an allosteric monoclonal antibody that reduces insulin receptor activity, as the antibody could have a major impact on the treatment of hyperinsulinism. for more information, visit www.xoma.com.



What does XOMA Royalty's logo look like?

XOMA Royalty Corp. logo

Complete history of Arthur Kornberg stock trades at XOMA Royalty

Date
#
Company
 Insider
Trans.
Transaction
 Shares Price per share Total value Shares after Source
11 May 2004 XOMA XOMA Royalty Corp. Arthur Md Kornberg
Director
 Option 1,000 $3.38 $3,380
11 May 2004
11,000 ↗


XOMA Royalty executives and stock owners

XOMA Royalty executives and other stock owners filed with the SEC include: